Quidel | QDEL - Equity Capital And Reserves


Quidel reported $1.85B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
Abbott USD 52.06B 69M Mar/2026
Agilent USD 7.12B 214M Mar/2026
Avanos Medical USD 782.1M 3.9M Mar/2026
Becton, Dickinson and Co. USD 24.13B 1.15B Mar/2026
Bruker USD 2.46B 35.9M Dec/2025
Cerus USD 64.22M 2.76M Dec/2025
Charles River Laboratories USD 2.9B 265.94M Mar/2026
Danaher USD 52.95B 415M Mar/2026
Haemonetics USD 796.32M 115.13M Mar/2026
Illumina USD 2.68B 47M Mar/2026
IQVIA Holdings USD 6.22B 282M Mar/2026
Merit Medical Systems USD 1.63B 42.42M Mar/2026
Mettler Toledo International USD -41.88M 18.25M Mar/2026
Myriad Genetics USD 337.4M 30.6M Mar/2026
Neogen USD 2.1B 2.09M Dec/2025
OraSure Technologies USD 313.32M 27.5M Mar/2026
Pacific Biosciences Of California USD 2.37M 2.98M Mar/2026
Quidel USD 1.85B 69.1M Mar/2026
Revvity USD 7.25B 125.54M Dec/2025
STAAR Surgical USD 352.37M 8.18M Mar/2026
Thermo Fisher Scientific USD 51.93B 1.6B Mar/2026
Waters USD 2.56B 230.55M Dec/2025